Medtronic plc (MDT)
Electromedical & Electrotherapeutic Apparatus · Electromedical & Electrotherapeutic Apparatus · NYSE
$92.09
+1.64%
Investingg Score
56.9 / 100
Hold
Business overview
- Operating margin of 17.8%
- Free cash flow margin of 14.9%
These profitability metrics indicate stable core operational efficiency, though broader business quality is counterbalanced by an overall financial quality score of 44.
Financial health
- Balance sheet pillar score of 51
- Free cash flow yield of 4.6%
These figures point to a moderate financial standing with reasonable cash generation capabilities, though specific debt figures are unavailable.
- Gross Margin
- Data unavailable
- Operating Margin
- 17.8%
- Current Ratio
- 2.1x
- Debt / Equity
- Data unavailable
- Free Cash Flow (TTM)
- $5.4B
- Interest Coverage
- Data unavailable
Valuation
- Price-to-earnings ratio of 24.3
- Price-to-sales ratio of 3.38
- Valuation pillar score of 61
These valuation multiples suggest a balanced pricing level relative to the broader sector, though future multiple expansion carries inherent uncertainty.
- P/E (TTM)
- 24.3x
- Forward P/E
- Data unavailable
- Price / Sales
- 3.4x
- EV / EBITDA
- Data unavailable
- FCF Yield
- 4.6%
Key risks
- Growth pillar score of 33 indicates potential deceleration concerns.
- Sideways technical trend suggests lack of clear directional momentum.
- Data unavailable for gross margin and enterprise value to EBITDA.
Market cap $117.9B · data as of 2026-08-18
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze MDT with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.